$60.00
Additional information
| Active substance | Tenofovir | 
|---|---|
| Water Retention | No significant effect | 
| Hepatotoxicity | Low risk | 
| Lab Test | Monitoring of renal function and bone density | 
| Also known as | TDF | 
| Blood pressure | No significant effect | 
| Trade name | Viread | 
| Storage conditions | Store at 20В°C to 25В°C (68В°F to 77В°F), excursions permitted between 15В°C to 30В°C (59В°F to 86В°F) | 
| Chemical name | 9-[(R)-2-[[Bis[[(isopropoxycarbonyl)oxy]methoxy]phosphinyl]methoxy]propyl]adenine fumarate (1:1) | 
| Formula | C19H30N5O10P В· C4H4O4 | 
| Substance class | Nucleotide reverse transcriptase inhibitor (NtRTI) | 
| Main action | Antiretroviral, inhibits HIV reverse transcriptase | 
| Half-life | Approximately 17 hours | 
| Dosage (medical) | 300 mg once daily | 
| Dosage (sports) | Not applicable | 
| Effects | Reduces the viral load in HIV-infected individuals, improves immune function | 
| Side effects | Nausea, vomiting, diarrhea, headache, dizziness, fatigue, renal impairment, bone loss | 
| Use in sports | None | 
| Manufacturer | Cipla Ltd. | 
| Packing | 30 tabs/bottle | 









